Cargando…
Inhalational System for Etoposide Liposomes: Formulation Development and In Vitro Deposition
Etoposide is a semisynthetic compound, widely used in treatment of non small cell lung cancer. However, frequent dosing and adverse effects remain a major concern in the use of etoposide. Liposomal systems for pulmonary drug delivery have been particularly attractive because of their compatibility w...
Autores principales: | Parmar, J. J., Singh, D. J., Lohade, A. A., Hegde, Darshana D., Soni, P. S., Samad, A., Menon, Mala D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480751/ https://www.ncbi.nlm.nih.gov/pubmed/23112400 http://dx.doi.org/10.4103/0250-474X.100240 |
Ejemplares similares
-
Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma
por: Parmar, J. J., et al.
Publicado: (2010) -
Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer
por: Singh, D. J., et al.
Publicado: (2012) -
Improvement of Inhalation Profile of DPI Formulations by Carrier Treatment with Magnesium Stearate
por: Hazare, Shruti, et al.
Publicado: (2009) -
Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
por: Ponkshe, Pranav, et al.
Publicado: (2023) -
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)